Entire Transcript in Adobe Acrobat Format - National Reference ...

5
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
Susan Old from the National Heart, Lung and Blood Institute
and then Patricia Barr with the National Action Plan on
Breast Cancer but we will have till about 9:30 to begin our
conversation.
We will add those two folks to the
conversation. We will resume it again and we will be able
to continue on till around 11:30, at which point there will
be comments by Harold and statements from the public. So
we have around two, two-and-a-half hours of actual
deliberation, and we look forward to having the members of
the other subcommittee join us in these conversations.
Our goal for this morning is to talk about
four, perhaps five, things. Some of them will take more
time than others.
I am going to do the first thing and I hope it
will not take long at all.
I am going to describe and try to defend our
decision to talk about research conducted in an anonymous -
- research conducted on tissue to be used in an anonymous
manner and explain how that differs from some of the ways
people had conceived of these tissue samples prior to our
work.
Secondly, Zeke Emanuel will describe the matrix
that we have been using to look at possible cases. That, I